480 related articles for article (PubMed ID: 23609752)
1. Regulation of chromatin structure via histone post-translational modification and the link to carcinogenesis.
Thompson LL; Guppy BJ; Sawchuk L; Davie JR; McManus KJ
Cancer Metastasis Rev; 2013 Dec; 32(3-4):363-76. PubMed ID: 23609752
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
Herranz M; Esteller M
Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
4. Histone onco-modifications.
Füllgrabe J; Kavanagh E; Joseph B
Oncogene; 2011 Aug; 30(31):3391-403. PubMed ID: 21516126
[TBL] [Abstract][Full Text] [Related]
5. Integrative Chemical Biology Approaches to Deciphering the Histone Code: A Problem-Driven Journey.
Li X; Li XD
Acc Chem Res; 2021 Oct; 54(19):3734-3747. PubMed ID: 34553920
[TBL] [Abstract][Full Text] [Related]
6. Context-specific regulation of cancer epigenomes by histone and transcription factor methylation.
Sarris M; Nikolaou K; Talianidis I
Oncogene; 2014 Mar; 33(10):1207-17. PubMed ID: 23503463
[TBL] [Abstract][Full Text] [Related]
7. Systems Level Analysis of Histone H3 Post-translational Modifications (PTMs) Reveals Features of PTM Crosstalk in Chromatin Regulation.
Schwämmle V; Sidoli S; Ruminowicz C; Wu X; Lee CF; Helin K; Jensen ON
Mol Cell Proteomics; 2016 Aug; 15(8):2715-29. PubMed ID: 27302890
[TBL] [Abstract][Full Text] [Related]
8. Dual Chromatin and Cytoskeletal Remodeling by SETD2.
Park IY; Powell RT; Tripathi DN; Dere R; Ho TH; Blasius TL; Chiang YC; Davis IJ; Fahey CC; Hacker KE; Verhey KJ; Bedford MT; Jonasch E; Rathmell WK; Walker CL
Cell; 2016 Aug; 166(4):950-962. PubMed ID: 27518565
[TBL] [Abstract][Full Text] [Related]
9. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
10. Mitotic accumulation of dimethylated lysine 79 of histone H3 is important for maintaining genome integrity during mitosis in human cells.
Guppy BJ; McManus KJ
Genetics; 2015 Feb; 199(2):423-33. PubMed ID: 25533199
[TBL] [Abstract][Full Text] [Related]
11. Targeting post-translational modifications of histones for cancer therapy.
Hsu YC; Hsieh YH; Liao CC; Chong LW; Lee CY; Yu YL; Chou RH
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(6):69-84. PubMed ID: 26518898
[TBL] [Abstract][Full Text] [Related]
12. Histone modification enzymes: novel targets for cancer drugs.
Kristeleit R; Stimson L; Workman P; Aherne W
Expert Opin Emerg Drugs; 2004 May; 9(1):135-54. PubMed ID: 15155140
[TBL] [Abstract][Full Text] [Related]
13. Post-translational modifications of lysine-specific demethylase 1.
Kim D; Nam HJ; Baek SH
Biochim Biophys Acta Gene Regul Mech; 2023 Dec; 1866(4):194968. PubMed ID: 37572976
[TBL] [Abstract][Full Text] [Related]
14. Lysine methylation: beyond histones.
Zhang X; Wen H; Shi X
Acta Biochim Biophys Sin (Shanghai); 2012 Jan; 44(1):14-27. PubMed ID: 22194010
[TBL] [Abstract][Full Text] [Related]
15. Histone post-translational modifications in DNA damage response.
Méndez-Acuña L; Di Tomaso MV; Palitti F; Martínez-López W
Cytogenet Genome Res; 2010; 128(1-3):28-36. PubMed ID: 20407219
[TBL] [Abstract][Full Text] [Related]
16. Preferential Phosphorylation on Old Histones during Early Mitosis in Human Cells.
Lin S; Yuan ZF; Han Y; Marchione DM; Garcia BA
J Biol Chem; 2016 Jul; 291(29):15342-57. PubMed ID: 27226594
[TBL] [Abstract][Full Text] [Related]
17. Histone H3 lysine 4 monomethylation (H3K4me1) and H3 lysine 9 monomethylation (H3K9me1): distribution and their association in regulating gene expression under hyperglycaemic/hyperinsulinemic conditions in 3T3 cells.
Gupta J; Kumar S; Li J; Krishna Murthy Karuturi R; Tikoo K
Biochimie; 2012 Dec; 94(12):2656-64. PubMed ID: 22951486
[TBL] [Abstract][Full Text] [Related]
18. Integrating Proteomics and Targeted Metabolomics to Understand Global Changes in Histone Modifications.
Simithy J; Sidoli S; Garcia BA
Proteomics; 2018 Sep; 18(18):e1700309. PubMed ID: 29512899
[TBL] [Abstract][Full Text] [Related]
19. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
20. H2AX: tailoring histone H2A for chromatin-dependent genomic integrity.
Li A; Eirín-López JM; Ausió J
Biochem Cell Biol; 2005 Aug; 83(4):505-15. PubMed ID: 16094454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
